Others have reported SIRT1 overexpression in primary and murine studies of prostate cancer [17,18] and found a requirement for SIRT1 for pro-survival signalling in oestrogen positive breast cancer, where expression also correlates with poor prognosis [19,20]. Here, SIRT1 is linked to breast carcinoma.